.Attributes Medication, Released online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Viewpoint calls for inclusion of individuals along with MASLD as well as size of liver end results in cardio-- renal-- metabolic tests, when data recommend mechanistically possible perks and medical security-- and outlines factors to consider for trial style as well as governing commendation.